Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain

被引：55

作者：

Ding, QX ^{[1
]}

Keller, JN ^{[1
]}

机构：

[1] Univ Kentucky, Dept Anat & Neurobiol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA

来源：

NEUROSCIENCE LETTERS | 2005年 / 373卷 / 01期

关键词：

Alzheimer's disease; amyloid-beta; brain; receptor for advanced glycosylation end products;

D O I：

10.1016/j.neulet.2004.09.059

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Previous studies indicate that the receptor for advanced glycosylation end products (RAGE) plays an important role in multiple pathological processes, including Alzheimer's disease. Currently there are three established isoforms of the RAGE receptor, with each isoform generated as the result of alternative splicing. It is presently unclear which of the RAGE isoforms are normally expressed in the human brain, nor has it been determined if additional RAGE isoforms exist in the human brain. In the present study we demonstrate for the first time that each of the three established RAGE isoforms, as well as three previously unidentified RAGE splicing variants, are normally expressed in the human brain. These data suggest that RAGE may have multiple functions in the human brain, mediated by the individual or coordinated efforts of the different RAGE isoforms, with alternative splicing generating individual RAGE isoforms that specifically interact with the various ligands present in the brain. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

引用

页码：67 / 72

页数：6

共 23 条

[1] RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease [J].

Bucciarelli, LG ;

Wendt, T ;

Rong, L ;

Lalla, E ;

Hofmann, MA ;

Goova, MT ;

Taguchi, A ;

Yan, SF ;

Yan, SD ;

Stern, DM ;

Schmidt, AM .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (07) :1117-1128

[2] The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques - Role of glycemic control [J].

Cipollone, F ;

Iezzi, A ;

Fazia, M ;

Zucchelli, M ;

Pini, B ;

Cuccurullo, C ;

De Cesare, D ;

De Blasis, G ;

Muraro, R ;

Bei, R ;

Chiarelli, F ;

Schmidt, AM ;

Cuccurullo, F ;

Mezzetti, A .

CIRCULATION, 2003, 108 (09) :1070-1077

[3] The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia [J].

Cooke, CLM ;

Brockelsby, JC ;

Baker, PN ;

Davidge, ST .

HYPERTENSION IN PREGNANCY, 2003, 22 (02) :173-+

[4] Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress [J].

Ding, QX ;

Reinacker, K ;

Dimayuga, E ;

Nukala, V ;

Drake, J ;

Butterfield, DA ;

Dunn, JC ;

Martin, S ;

Bruce-Keller, AJ ;

Keller, JN .

FEBS LETTERS, 2003, 546 (2-3) :228-232

[5] Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival [J].

Ding, QX ;

Lewis, JJ ;

Strum, KM ;

Dimayuga, E ;

Bruce-Keller, AJ ;

Dunn, JC ;

Keller, JN .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13935-13942

[6] Effect of endothelial cell polarity on β-amyloid-induced migration of monocytes across normal and AD endothelium [J].

Giri, R ;

Selvaraj, S ;

Miller, CA ;

Hofman, F ;

Yan, SD ;

Stern, D ;

Zlokovic, BV ;

Kalra, VK .

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 283 (03) :C895-C904

[7] Sequencing of two alternatively spliced mRNAs corresponding to the extracellular domain of the rat receptor for advanced glycosylation end products (RAGE) [J].

Girón, MD ;

Vargas, AM ;

Suárez, MD ;

Salto, R .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 251 (01) :230-234

[8]

Hammes HP, 1999, INVEST OPHTH VIS SCI, V40, P1855

[9] Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression [J].

Kislinger, T ;

Fu, CF ;

Huber, B ;

Qu, W ;

Taguchi, A ;

Yan, SD ;

Hofmann, M ;

Yan, SF ;

Pischetsrieder, M ;

Stern, D ;

Schmidt, AM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (44) :31740-31749

[10] Differential effects between amphoterin and advanced glycation end products on colon cancer cells [J].

Kuniyasu, H ;

Chihara, Y ;

Kondo, H .

INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (06) :722-727

← 1 2 3 →